Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy
- PMID: 21196249
- PMCID: PMC3066103
- DOI: 10.2741/3806
Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy
Abstract
The anthrax toxin receptors tumor endothelial marker-8 (TEM-8) and capillary morphogenesis gene-2 (CMG-2) are responsible for allowing entry of anthrax toxin into host cells. These receptors were first discovered due to their enhanced expression on endothelial cells undergoing blood vessel growth or angiogenesis in model systems. Inhibition of angiogenesis is an important strategy for current anti-cancer therapies and treatment of retinal diseases. Functional roles for TEM-8 and CMG-2 in angiogenesis have recently emerged. TEM-8 appears to regulate endothelial cell migration and tubule formation whereas a role for CMG-2 in endothelial proliferation has been documented. TEM-8 and CMG-2 bind differentially to extracellular matrix proteins including collagen I, collagen IV and laminin and these properties may be responsible for their apparent roles in regulating endothelial cell behavior during angiogenesis. TEM-8-binding moieties have also been suggested to be useful in selectively targeting anti-angiogenic and anti-tumorigenic therapies to tumor endothelium. Additionally, studies of modified forms of lethal toxin (LeTx) have demonstrated that targeted inhibition of MAPKs within tumor vessels may represent an efficacious anti-angiogenic strategy.
Figures


Similar articles
-
Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.Cancer Res. 2007 Oct 15;67(20):9980-5. doi: 10.1158/0008-5472.CAN-07-0829. Cancer Res. 2007. PMID: 17942931
-
Targeted silencing of anthrax toxin receptors protects against anthrax toxins.J Biol Chem. 2014 May 30;289(22):15730-8. doi: 10.1074/jbc.M113.538587. Epub 2014 Apr 17. J Biol Chem. 2014. PMID: 24742682 Free PMC article.
-
Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.J Biol Chem. 2007 Mar 30;282(13):9834-9845. doi: 10.1074/jbc.M611142200. Epub 2007 Jan 24. J Biol Chem. 2007. PMID: 17251181 Free PMC article.
-
Potent inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin: implications for broad anti-tumor efficacy.Cell Cycle. 2008 Mar 15;7(6):745-9. doi: 10.4161/cc.7.6.5627. Epub 2008 Jan 18. Cell Cycle. 2008. PMID: 18245947 Review.
-
Interactions between anthrax toxin receptors and protective antigen.Curr Opin Microbiol. 2005 Feb;8(1):106-12. doi: 10.1016/j.mib.2004.12.005. Curr Opin Microbiol. 2005. PMID: 15694864 Review.
Cited by
-
Cytoskeleton as an emerging target of anthrax toxins.Toxins (Basel). 2012 Feb;4(2):83-97. doi: 10.3390/toxins4020083. Epub 2012 Feb 6. Toxins (Basel). 2012. PMID: 22474568 Free PMC article. Review.
-
Solid tumor therapy by selectively targeting stromal endothelial cells.Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):E4079-87. doi: 10.1073/pnas.1600982113. Epub 2016 Jun 29. Proc Natl Acad Sci U S A. 2016. PMID: 27357689 Free PMC article.
-
In situ targeting TEM8 via immune response and polypeptide recognition by wavelength-modulated surface plasmon resonance biosensor.Sci Rep. 2016 Jan 29;6:20006. doi: 10.1038/srep20006. Sci Rep. 2016. PMID: 26822761 Free PMC article.
-
Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.Cell Res. 2015 Feb;25(2):157-68. doi: 10.1038/cr.2014.169. Epub 2014 Dec 30. Cell Res. 2015. PMID: 25547119 Free PMC article.
-
A novel model for evaluating therapies targeting human tumor vasculature and human cancer stem-like cells.Cancer Res. 2013 Jun 15;73(12):3555-65. doi: 10.1158/0008-5472.CAN-12-2845. Epub 2013 Apr 10. Cancer Res. 2013. PMID: 23576551 Free PMC article.
References
-
- Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, Maxwell SA, Davis GE. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci. 2001;114:2755–2773. - PubMed
-
- St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW. Genes expressed in human tumor endothelium. Science. 2000;289:1197–1202. - PubMed
-
- Mock M, Fouet A. Anthrax. Annu Rev Microbiol. 2001;55:647–671. - PubMed
-
- Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA. Identification of the cellular receptor for anthrax toxin. Nature. 2001;414:225–229. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources